Ross Walenga

1.3k total citations
52 papers, 979 citations indexed

About

Ross Walenga is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Physiology. According to data from OpenAlex, Ross Walenga has authored 52 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 13 papers in Pharmaceutical Science and 12 papers in Physiology. Recurrent topics in Ross Walenga's work include Inhalation and Respiratory Drug Delivery (38 papers), Asthma and respiratory diseases (10 papers) and Aerosol Filtration and Electrostatic Precipitation (10 papers). Ross Walenga is often cited by papers focused on Inhalation and Respiratory Drug Delivery (38 papers), Asthma and respiratory diseases (10 papers) and Aerosol Filtration and Electrostatic Precipitation (10 papers). Ross Walenga collaborates with scholars based in United States, Australia and South Korea. Ross Walenga's co-authors include P. Worth Longest, Michael Hindle, Geng Tian, Andrew Babiskin, Laleh Golshahi, Yoen‐Ju Son, Renishkumar Delvadia, Guoguang Su, Andrzej Przekwas and Liang Zhao and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Applied Physiology and Journal of Controlled Release.

In The Last Decade

Ross Walenga

49 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross Walenga United States	18	788	273	141	139	139	52	979
Stephen W. Stein United States	18	893 1.1×	194 0.7×	82 0.6×	150 1.1×	259 1.9×	35	1.1k
Renishkumar Delvadia United States	14	545 0.7×	171 0.6×	70 0.5×	100 0.7×	140 1.0×	17	612
Xiuhua Si United States	11	409 0.5×	126 0.5×	67 0.5×	47 0.3×	56 0.4×	32	541
Craig Dunbar United States	14	551 0.7×	142 0.5×	68 0.5×	176 1.3×	69 0.5×	20	672
Tanya Church United Kingdom	15	429 0.5×	120 0.4×	64 0.5×	63 0.5×	86 0.6×	36	545
Landon T. Holbrook United States	8	335 0.4×	136 0.5×	72 0.5×	35 0.3×	42 0.3×	12	423
G. M. Schum United States	8	939 1.2×	300 1.1×	128 0.9×	29 0.2×	113 0.8×	12	1.1k
Gary R. Pitcairn United Kingdom	20	999 1.3×	94 0.3×	30 0.2×	174 1.3×	474 3.4×	32	1.1k
Yoen‐Ju Son United States	15	645 0.8×	111 0.4×	27 0.2×	225 1.6×	98 0.7×	19	717
Doetie Gjaltema Netherlands	11	594 0.8×	148 0.5×	37 0.3×	107 0.8×	162 1.2×	15	637

Countries citing papers authored by Ross Walenga

Since Specialization

Citations

This map shows the geographic impact of Ross Walenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Walenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Walenga more than expected).

Fields of papers citing papers by Ross Walenga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Walenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Walenga. The network helps show where Ross Walenga may publish in the future.

Co-authorship network of co-authors of Ross Walenga

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Walenga. A scholar is included among the top collaborators of Ross Walenga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Walenga. Ross Walenga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walenga, Ross, Andrew Babiskin, Xin Feng, et al.. (2025). Nasal absorption of oxycodone predicted using a novel computational fluid dynamics-physiologically based pharmacokinetic model. Journal of Controlled Release. 378. 982–996.

Dutta, Rabijit, Arun V. Kolanjiyil, Ross Walenga, et al.. (2024). CFD-PK model for nasal suspension sprays: Validation with human adult in vivo data for triamcinolone acetonide. International Journal of Pharmaceutics. 665. 124660–124660. 3 indexed citations

Walenga, Ross, Andrew Babiskin, James F. Clarke, et al.. (2024). Use of the Same Model or Modeling Strategy Across Multiple Submissions: Focus on Complex Drug Products. The AAPS Journal. 26(1). 12–12. 1 indexed citations

Wu, Fang, Ross Walenga, Eleftheria Tsakalozou, et al.. (2024). Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research Initiatives Public Workshop. The AAPS Journal. 26(3). 45–45.

Khadka, Prakash, Michael Hindle, Theodore A. Schuman, et al.. (2024). Anatomically-detailed segmented representative adult and pediatric nasal models for assessing regional drug delivery and bioequivalence with suspension nasal sprays. International Journal of Pharmaceutics. 666. 124743–124743. 3 indexed citations

Kimbell, Julia S., Guilherme J. M. Garcia, Poonam Sheth, et al.. (2023). Nasal steroid spray simulations using measured spray characteristics in healthy and rhinitic nasal passages. Journal of Aerosol Science. 174. 106246–106246. 5 indexed citations

Babiskin, Andrew, Fang Wu, Ming‐Liang Tan, et al.. (2023). Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview. CPT Pharmacometrics & Systems Pharmacology. 12(5). 619–623. 10 indexed citations

Tang, Patricia A., et al.. (2023). The role of capsule aperture size on the dispersion of carrier-based formulation at different air flowrates. International Journal of Pharmaceutics. 642. 123152–123152. 3 indexed citations

German, Carrie, Zhijian J. Chen, Andrzej Przekwas, et al.. (2023). Computational Model of In Vivo Corneal Pharmacokinetics and Pharmacodynamics of Topically Administered Ophthalmic Drug Products. Pharmaceutical Research. 40(4). 961–975. 4 indexed citations

10.

Kolanjiyil, Arun V., Ross Walenga, Andrew Babiskin, et al.. (2023). Establishing quantitative relationships between changes in nasal spray in vitro metrics and drug delivery to the posterior nasal region. International Journal of Pharmaceutics. 635. 122718–122718. 5 indexed citations

11.

Choi, Jiwoong, et al.. (2023). Transport and deposition of beclomethasone dipropionate drug aerosols with varying ethanol concentration in severe asthmatic subjects. International Journal of Pharmaceutics. 636. 122805–122805. 5 indexed citations

12.

Jayasundara, C.T., et al.. (2023). CFD-DEM investigation of the effects of aperture size for a capsule-based dry powder inhaler. International Journal of Pharmaceutics. 647. 123556–123556. 7 indexed citations

13.

Singh, Narender, et al.. (2021). A quasi-3D model of the whole lung: airway extension to the tracheobronchial limit using the constrained constructive optimization and alveolar modeling, using a sac–trumpet model. Journal of Computational Design and Engineering. 8(2). 691–704. 3 indexed citations

14.

Manniello, Michele Dario, Sana Hosseini, Amir R. Esmaeili, et al.. (2020). In vitro evaluation of regional nasal drug delivery using multiple anatomical nasal replicas of adult human subjects and two nasal sprays. International Journal of Pharmaceutics. 593. 120103–120103. 27 indexed citations

15.

Choi, Jiwoong, Lawrence J. LeBlanc, Sanghun Choi, et al.. (2019). Differences in Particle Deposition Between Members of Imaging-Based Asthma Clusters. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(4). 213–223. 24 indexed citations

16.

Walenga, Ross, et al.. (2018). Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup Time. Journal of Pharmaceutical Sciences. 108(1). 620–629. 19 indexed citations

17.

Walenga, Ross, et al.. (2017). Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30(3). 190–205. 22 indexed citations

18.

Przekwas, Andrzej, et al.. (2017). Computational modeling of drug transport across the in vitro cornea. Computers in Biology and Medicine. 92. 139–146. 17 indexed citations

19.

Walenga, Ross & P. Worth Longest. (2016). Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs. Journal of Pharmaceutical Sciences. 105(1). 147–159. 45 indexed citations

20.

Longest, P. Worth, Ross Walenga, Yoen‐Ju Son, & Michael Hindle. (2012). High-Efficiency Generation and Delivery of Aerosols Through Nasal Cannula During Noninvasive Ventilation. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26(5). 266–279. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact